Noa Therapeutics Inc. (Noa) is a Canadian pre-clinical biotech company aiming to revolutionize treatment options for inflammatory skin diseases. Leveraging intelligent design, Noa is pioneering the development of first-in-class trimodal therapeutics. These non-steroidal small molecules simultaneously address three critical elements of epidermal dysfunction, to safely, rapidly and effectively resolve inflammatory skin disease across all populations.